Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a research note issued on Sunday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.84 on Friday. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $25.15 million, a price-to-earnings ratio of -1.56 and a beta of 1.96. The firm’s 50 day simple moving average is $0.75 and its 200 day simple moving average is $0.78. Retractable Technologies has a 1 year low of $0.56 and a 1 year high of $1.34.

Hedge Funds Weigh In On Retractable Technologies

Several institutional investors and hedge funds have recently added to or reduced their stakes in RVP. PFG Investments LLC bought a new position in Retractable Technologies in the 3rd quarter valued at approximately $27,000. Renaissance Technologies LLC lifted its stake in Retractable Technologies by 9.4% in the 4th quarter. Renaissance Technologies LLC now owns 361,253 shares of the company’s stock valued at $249,000 after purchasing an additional 31,140 shares during the last quarter. Finally, Wealthfront Advisers LLC bought a new position in Retractable Technologies in the 4th quarter valued at approximately $1,748,000. Institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.